• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨髓细胞移植时间依赖性地消除了高血压大鼠中风后粒细胞集落刺激因子的疗效。

Bone marrow cell transplantation time-dependently abolishes efficacy of granulocyte colony-stimulating factor after stroke in hypertensive rats.

机构信息

From the Fraunhofer Institute for Cell Therapy and Immunology, Leipzig, Germany (C.P., J.S., A.K., E.Q., W.F., F.L., J.B., D.-C.W.); Translational Centre for Regenerative Medicine, Leipzig, Germany (A.K., V.B., E.Q., W.F., J.B., D.-C.W.); EVK Bielefeld, Bethel, Neurologische Klinik, Bielefeld, Germany (W.-R.S.); Department of Neurology, University of Münster, Germany (J.M.); and Massachusetts General Hospital and Harvard Medical School, Boston (J.B.).

出版信息

Stroke. 2014 Aug;45(8):2431-7. doi: 10.1161/STROKEAHA.113.004460. Epub 2014 Jul 1.

DOI:10.1161/STROKEAHA.113.004460
PMID:24984745
Abstract

BACKGROUND AND PURPOSE

We aimed to determine a possible synergistic effect of granulocyte colony-stimulating factor (G-CSF) and bone marrow-derived mononuclear cells (BM MNC) after stroke in spontaneously hypertensive rats.

METHODS

Male spontaneously hypertensive rats were subjected to middle cerebral artery occlusion and randomly assigned to daily injection of 50 μg/kg G-CSF for 5 days starting 1 hour after stroke (groups 1, 2, and 3) with additional intravenous transplantation of 1.5×10E7 BM MNC per kilogram at 6 hours (group 2) or 48 hours (group 3) after stroke, or control treatment (group 4). Circulating leukocyte counts and functional deficits, infarct volume, and brain edema were repeatedly assessed in the first week and first month.

RESULTS

G-CSF treatment led to a significant neutrophilia, to a reversal of postischemic depression of circulating leukocytes, and to a significantly improved functional recovery without affecting the infarct volume or brain edema. BM MNC cotransplantation was neutral after 6 hours, but reversed the functional effect of G-CSF after 48 hours. Short-term investigation of combined G-CSF and BM MNC treatment at 48 hours indicated splenic accumulation of granulocytes and transplanted cells, accompanied by a significant rise of granulocytes in the circulation and the ischemic brain.

CONCLUSIONS

G-CSF improved functional recovery in spontaneously hypertensive rats, but this effect was abolished by cotransplantation of BM MNC after 48 hours. In the spleen, transplanted cells may hinder the clearance of granulocytes that were massively increased by G-CSF. Increased circulation and infiltration of granulocytes into the ischemic brain may be detrimental for stroke outcome.

摘要

背景与目的

我们旨在确定粒细胞集落刺激因子(G-CSF)和骨髓来源的单核细胞(BM MNC)在自发性高血压大鼠中风后的协同作用。

方法

雄性自发性高血压大鼠接受大脑中动脉闭塞,并随机分为中风后 1 小时开始每天注射 50μg/kg G-CSF 5 天的组(1、2 和 3 组),并在中风后 6 小时(2 组)或 48 小时(3 组)额外静脉内移植每公斤 1.5×10E7 BM MNC,或接受对照治疗(4 组)。在第一周和第一个月内,反复评估循环白细胞计数和功能缺陷、梗死体积和脑水肿。

结果

G-CSF 治疗导致显著的中性粒细胞增多,逆转了缺血后循环白细胞的抑制,并显著改善了功能恢复,而不影响梗死体积或脑水肿。BM MNC 共移植在 6 小时后呈中性,但在 48 小时后逆转了 G-CSF 的功能作用。对 48 小时联合 G-CSF 和 BM MNC 治疗的短期研究表明,粒细胞和移植细胞在脾脏蓄积,同时循环和缺血性脑内的粒细胞显著增加。

结论

G-CSF 改善了自发性高血压大鼠的功能恢复,但在 48 小时后共移植 BM MNC 会消除这种作用。在脾脏中,移植细胞可能会阻碍因 G-CSF 而大量增加的粒细胞的清除。循环中粒细胞的增加和浸润到缺血性脑内可能对中风结果有害。

相似文献

1
Bone marrow cell transplantation time-dependently abolishes efficacy of granulocyte colony-stimulating factor after stroke in hypertensive rats.骨髓细胞移植时间依赖性地消除了高血压大鼠中风后粒细胞集落刺激因子的疗效。
Stroke. 2014 Aug;45(8):2431-7. doi: 10.1161/STROKEAHA.113.004460. Epub 2014 Jul 1.
2
Granulocyte colony-stimulating factor and bone marrow mononuclear cells for stroke treatment in the aged brain.粒细胞集落刺激因子和骨髓单个核细胞用于老年脑中风的治疗
Curr Neurovasc Res. 2015;12(2):155-62. doi: 10.2174/1567202612666150311112550.
3
Granulocyte colony-stimulating factor (G-CSF) treatment in combination with transplantation of bone marrow cells is not superior to G-CSF treatment alone after cortical stroke in spontaneously hypertensive rats.粒细胞集落刺激因子(G-CSF)治疗联合骨髓细胞移植在自发性高血压大鼠皮质卒中后并不优于 G-CSF 单独治疗。
Front Cell Neurosci. 2014 Dec 4;8:411. doi: 10.3389/fncel.2014.00411. eCollection 2014.
4
Impact of the neutrophil response to granulocyte colony-stimulating factor on the risk of hemorrhage when used in combination with tissue plasminogen activator during the acute phase of experimental stroke.实验性中风急性期,中性粒细胞对粒细胞集落刺激因子的反应在与组织型纤溶酶原激活剂联合使用时对出血风险的影响。
J Neuroinflammation. 2014 May 27;11:96. doi: 10.1186/1742-2094-11-96.
5
Successful regeneration after experimental stroke by granulocyte-colony stimulating factor is not further enhanced by constraint-induced movement therapy either in concurrent or in sequential combination therapy.实验性中风后,粒细胞集落刺激因子治疗后的成功再生,无论是在同时联合治疗还是序贯联合治疗中,都不能进一步通过强制性运动疗法得到增强。
Stroke. 2012 Jan;43(1):185-92. doi: 10.1161/STROKEAHA.111.622159. Epub 2011 Oct 20.
6
Granulocyte colony-stimulating factor enhances arteriogenesis and ameliorates cerebral damage in a mouse model of ischemic stroke.粒细胞集落刺激因子增强缺血性中风小鼠模型的血管生成并改善脑损伤。
Stroke. 2011 Mar;42(3):770-5. doi: 10.1161/STROKEAHA.110.597799. Epub 2011 Jan 21.
7
Intra-arterial bone marrow mononuclear cells in ischemic stroke: a pilot clinical trial.动脉内骨髓单核细胞治疗缺血性脑卒中:一项初步临床试验。
Stroke. 2012 Aug;43(8):2242-4. doi: 10.1161/STROKEAHA.112.659409. Epub 2012 Jul 3.
8
Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.自体骨髓移植后,人骨髓髓系祖细胞对单独使用粒细胞集落刺激因子以及联合白细胞介素-3进行体内治疗的增殖反应。
Exp Hematol. 1995 Dec;23(14):1520-6.
9
Strategies to improve post-stroke behavioral recovery in aged subjects.改善老年中风患者行为恢复的策略。
Rom J Morphol Embryol. 2009;50(4):559-82.
10
Combining Growth Factor and Bone Marrow Cell Therapy Induces Bleeding and Alters Immune Response After Stroke in Mice.联合生长因子与骨髓细胞疗法可诱发小鼠中风后出血并改变免疫反应。
Stroke. 2016 Mar;47(3):852-62. doi: 10.1161/STROKEAHA.115.011230. Epub 2016 Feb 2.

引用本文的文献

1
Cell-Based Therapies for Stroke: Promising Solution or Dead End? Mesenchymal Stem Cells and Comorbidities in Preclinical Stroke Research.中风的细胞疗法:是充满希望的解决方案还是死胡同?临床前中风研究中的间充质干细胞与合并症
Front Neurol. 2019 Apr 9;10:332. doi: 10.3389/fneur.2019.00332. eCollection 2019.
2
Future of Animal Modeling for Poststroke Tissue Repair.中风后组织修复动物模型的未来
Stroke. 2018 May;49(5):1099-1106. doi: 10.1161/STROKEAHA.117.018293. Epub 2018 Apr 18.
3
Bone Marrow Stromal Cells Combined With Sodium Ferulate and -Butylidenephthalide Promote the Effect of Therapeutic Angiogenesis via Advancing Astrocyte-Derived Trophic Factors After Ischemic Stroke.
骨髓基质细胞联合阿魏酸钠和丁苯酞通过促进缺血性脑卒中后星形胶质细胞源性营养因子来增强治疗性血管生成的效果。
Cell Transplant. 2017 Feb 16;26(2):229-242. doi: 10.3727/096368916X693536. Epub 2016 Oct 21.
4
Is Immunomodulation a Principal Mechanism Underlying How Cell-Based Therapies Enhance Stroke Recovery?免疫调节是基于细胞的疗法促进中风恢复的主要机制吗?
Neurotherapeutics. 2016 Oct;13(4):775-782. doi: 10.1007/s13311-016-0468-9.
5
Recurrent mild cerebral ischemia: enhanced brain injury following acute compared to subacute recurrence in the rat.复发性轻度脑缺血:与亚急性复发相比,大鼠急性复发后脑损伤加重。
BMC Neurosci. 2016 May 26;17(1):28. doi: 10.1186/s12868-016-0263-x.
6
The Dark Side of the Force - Constraints and Complications of Cell Therapies for Stroke.原力的黑暗面——中风细胞疗法的限制与并发症
Front Neurol. 2015 Jul 20;6:155. doi: 10.3389/fneur.2015.00155. eCollection 2015.
7
Granulocyte colony-stimulating factor (G-CSF) treatment in combination with transplantation of bone marrow cells is not superior to G-CSF treatment alone after cortical stroke in spontaneously hypertensive rats.粒细胞集落刺激因子(G-CSF)治疗联合骨髓细胞移植在自发性高血压大鼠皮质卒中后并不优于 G-CSF 单独治疗。
Front Cell Neurosci. 2014 Dec 4;8:411. doi: 10.3389/fncel.2014.00411. eCollection 2014.